Quick answer : Ketamine has abuse and dependence potential, but medically supervised ketamine treatment is very different from recreational ketamine use. Clinical treatment uses controlled dosing, screening, monitoring, and defined treatment intervals. Patients with current or previous substance use disorders require individualized risk assessment, and ketamine should not be described as completely non-addictive simply because it is being used medically.
Ketamine occupies an unusual position in medicine. It has been used as an anesthetic for decades and is now increasingly used at subanesthetic doses for treatment-resistant depression and other psychiatric conditions.
At the same time, ketamine is also used recreationally and can be misused. Chronic heavy use has been associated with dependence and serious medical complications.
It is therefore reasonable for someone considering ketamine therapy to ask whether receiving it for depression could lead to addiction.
No. The context, dosing pattern, monitoring, and purpose are very different.
In a medically supervised program, the clinician knows the dose being administered and has evaluated the patient’s medical and psychiatric history. Treatments occur according to a defined plan, and the clinical team can monitor response, adverse effects, and whether continued treatment remains appropriate.
Recreational use can involve uncertain doses, frequent exposure, combinations with other substances, and no clinical monitoring.
However, saying these situations are different should not be interpreted to mean medically administered ketamine has zero abuse potential. It is still ketamine, and risk should be taken seriously.
These terms are often used interchangeably, but they describe different concepts.
Tolerance means that repeated exposure to a drug results in a reduced effect, potentially leading someone to seek a higher dose to achieve the same effect. Physical dependence refers to physiologic adaptation that can produce withdrawal symptoms when a drug is stopped.
Addiction, or substance use disorder, involves a problematic pattern of use characterized by features such as impaired control, craving, continued use despite harm, or significant disruption of normal life.
A patient can develop tolerance or physical dependence to certain medications without meeting criteria for addiction, although these phenomena can overlap.
A careful assessment should include alcohol, cannabis, opioids, stimulants, sedatives, previous ketamine use, and any history of substance use disorder.
The presence of a substance use history does not automatically determine whether someone can or cannot receive ketamine. The substance involved, current use, severity, duration of recovery, treatment supports, psychiatric diagnosis, and individual risk all matter.
For some patients, coordination with an addiction specialist or existing mental health clinician may be appropriate.
Ketamine can produce acute psychoactive effects, including dissociation and altered perception. Some people find these experiences meaningful, while others find them unpleasant or relatively unimportant.
Research has not established that a stronger dissociative or psychoactive experience is necessary for an antidepressant response. Systematic reviews have found inconsistent relationships between the intensity of acute subjective effects and clinical outcomes.
That distinction matters because treatment should focus on clinical improvement rather than chasing an increasingly intense experience.
Any long-term medical treatment should periodically answer several questions. Is it still helping? Is the current frequency necessary? Are adverse effects emerging? Are there signs that the patient’s relationship with the treatment is changing?
If someone begins requesting increasingly frequent treatments without clear clinical justification, escalating doses primarily to reproduce subjective effects, or using ketamine outside the treatment plan, those changes deserve attention.
The goal should be the lowest treatment burden that maintains meaningful benefit rather than indefinite escalation.
Ketamine has genuine abuse and dependence potential, and describing it as completely non-addictive would be inaccurate. At the same time, structured medical treatment is fundamentally different from uncontrolled recreational use.
Appropriate screening, controlled administration, monitoring, and periodic reassessment can help clinicians balance ketamine’s therapeutic potential against its risks.
Yes. Ketamine can be misused, and dependence can occur, particularly with frequent or uncontrolled exposure. Chronic ketamine misuse is associated with significant psychiatric and physical complications.
No. Medical ketamine involves known dosing, clinical screening, controlled administration, and monitoring. Recreational use may involve very different doses and patterns of exposure. The underlying medication still has abuse potential.
Potentially, but the decision requires individualized assessment. Current substance use, previous substance use disorder, recovery stability, psychiatric diagnosis, support system, and overall risk should all be considered.
